FDA 执法报告 D-0031-2027:Carolina Infusion 复方注射剂因无菌保证不足被列为 II 类召回
FDA drug enforcement D-0031-2027: Carolina Infusion, LLC — Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
openFDA 药品执法报告 D-0031-2027 显示,Carolina Infusion 的复方注射剂 Tri-MIX(PAPAV/PHENTO/ALPROS)30/2/20 因无菌保证不足被列为 II 类召回。
记录列出该复方注射剂的召回等级、批号与全国配送范围,可用于核对本次召回的覆盖边界。
FDA 药品召回执法报告 — D-0031-2027
报告发布日期:2026-10-14。这是执法报告日期,不是召回启动日期。
范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。
openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所对应的含义。
完整官方产品记录(包括 openFDA 统一标识符):
{
"address_1": "95 Bees Creek Rd",
"address_2": "N/A",
"center_classification_date": "20261008",
"city": "Ridgeland",
"classification": "Class II",
"code_info": "Lot: 07212026@1, BUD: 9/10/2026.",
"country": "United States",
"distribution_pattern": "Nationwide within the U.S",
"event_id": "99867",
"initial_firm_notification": "E-Mail",
"openfda": {},
"postal_code": "29936-7540",
"product_description": "Tri-MIX (PAPAV/PHENTO/ALPROS),30/2/20, injectable, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936",
"product_quantity": "10 ml -in patient specific syringe dose",
"product_type": "Drugs",
"reason_for_recall": "Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.",
"recall_initiation_date": "20260910",
"recall_number": "D-0031-2027",
"recalling_firm": "Carolina Infusion, LLC",
"report_date": "20261014",
"state": "SC",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov